Myelofibrosis (MF)
Filters
All Videos
Winship Cancer Institute - Emory University
Myelofibrosis: To JAK Inhibitors and Beyond
FEATURING
Michael J. Hochman
- 69 views
- February 25, 2025
Oncology 2024 Year in Review
Year in Review 2024 - Highlights in MPNs and Impact on Practice
FEATURING
Prithviraj Bose
- 94 views
- February 24, 2025
Robert Peter Gale
Overview of Myelofibrosis: Diagnosis, Current Therapies, Symptom Control, and Challenges
- 91 views
- February 24, 2025
16th International Congress on Myeloproliferative Neoplasms
Current Status of Ropeginterferon Studies in MPNs
FEATURING
Heinz Gisslinger
- 13 views
- February 10, 2025
David Ross
Importance of Early Intervention in Symptomatic Myelofibrosis and Splenomegaly, Regardless of Anemia
- 38 views
- February 10, 2025
16th International Congress on Myeloproliferative Neoplasms
Influence of Germline Mutations on MPN Phenotype
FEATURING
Jyoti Nangalia
- 13 views
- February 10, 2025
- 1
GRACE
Myeloproliferative Neoplasms 101: Epidemiology, Etiology, and Diagnosis
FEATURING
Andrew Srisuwananukorn
- 26 views
- February 6, 2025
Akhil Jain
Overview of Myelofibrosis: Pathogenesis, Diagnosis, and Prognostic Models
- 84 views
- January 31, 2025
- 1
Akhil Jain
Overview of Myelofibrosis: Management, JAK Inhibitor Trials, and Emerging Therapies
- 125 views
- January 31, 2025
Jeanne Palmer
Momelotinib in MF: Insights from SIMPLIFY-1, SIMPLIFY-2, and MOMENTUM Trials
- 161 views
- January 30, 2025
Winship Cancer Institute - Emory University
COMFORT-1 Trial Long-Term Follow-Up: Impact of Ruxolitinib on OS for Myelofibrosis Patients
FEATURING
Anthony Hunter
- 158 views
- December 31, 2024
- 1
2024 ASH Annual Meeting Insights Hub
ASH 2024 Insights: Ph3 BOREAS Study - Navtemadlin vs. Best Available Therapy in JAK Inhibitor R/R MF
FEATURING
John Mascarenhas
- 52 views
- December 27, 2024
2024 ASH Annual Meeting Insights Hub
ASH 2024 Summary: MPN Highlights and Clinical Implications
FEATURING
Douglas Tremblay
- 755 views
- December 18, 2024
- 2
2024 ASH Annual Meeting Insights Hub
ASH 2024 Summary: Pegylated Interferon in MPN - The Who, Why, and How
FEATURING
Jean-Jacques Kiladjian
- 286 views
- December 17, 2024
- 4
The University of Kansas Cancer Center
Prioritizing Overall Survival in MF: Longterm Updates From COMFORT-I and II Studies
FEATURING
Abdulraheem Yacoub
- 77 views
- December 16, 2024
16th International Congress on Myeloproliferative Neoplasms
MPNs in Children, Adolescents, and Young Adults
FEATURING
Nicole Kucine
- 27 views
- December 5, 2024
16th International Congress on Myeloproliferative Neoplasms
Polycythemia Vera Progression: Prevention and Prediction
FEATURING
Ghaith Abu-Zeinah
- 51 views
- December 4, 2024
16th International Congress on Myeloproliferative Neoplasms
The Importance of Chromosomes in MPN in 2024
FEATURING
Vesna Najfeld
- 20 views
- December 4, 2024
16th International Congress on Myeloproliferative Neoplasms
Novel Agents for MPNs in 2024
FEATURING
Naveen Pemmaraju
- 208 views
- December 3, 2024
- 1
16th International Congress on Myeloproliferative Neoplasms
Selection of JAK1/2 Inhibitors for Primary Myelofibrosis
FEATURING
Aaron Gerds
- 101 views
- December 3, 2024
16th International Congress on Myeloproliferative Neoplasms
Predictors of Allogeneic Transplantation Outcome in Primary Myelofibrosis
FEATURING
Koen van Besien
- 60 views
- November 26, 2024
16th International Congress on Myeloproliferative Neoplasms
Allele Burden in MPN: Practical Considerations
FEATURING
Raajit Rampal
- 235 views
- November 26, 2024
- 1
16th International Congress on Myeloproliferative Neoplasms
Clinical and Therapeutic Aspects of Chronic Inflammation in the MPNs
FEATURING
Hans Hasselbalch
- 62 views
- November 26, 2024
- 1
GRACE
Approach to Selecting Treatment for Myelofibrosis in 2024
FEATURING
Andrew Srisuwananukorn
- 64 views
- November 25, 2024
Alexander Coltoff
Survival as a Primary Goal in MF: Evaluating 5-Yr Data From COMFORT-1
- 128 views
- November 5, 2024
UChicago Medicine
Current Management of Accelerated/Blast-Phase MPNs
FEATURING
Anand Patel
- 86 views
- October 25, 2024
- 1
Cleveland Clinic Taussig Cancer Institute
Updates in MPNs From ASH 2023
FEATURING
Rebecca B. Klisovic
- 16 views
- October 22, 2024
Yale Cancer Center
Myeloid Malignancies: Hot Topics in 2024
FEATURING
Nikolai Podoltsev
- 378 views
- October 21, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Current and Future Treatment Landscape of Myelofibrosis
FEATURING
Rami Komrokji
- 242 views
- October 8, 2024
- 2
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Myelofibrosis Case Discussion: Patient With Splanchnic Venous Thrombosis
FEATURING
Weronika Lebowa
- 19 views
- September 25, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights in Heme Malignancies
FEATURING
Maria Gomes da Silva
- 585 views
- September 23, 2024
- 2
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Retrospective Analysis of Primary MF Patients in Azerbaijan
FEATURING
Elmir Guluyev
- 15 views
- September 16, 2024
MyCancerHaven
Experts Discuss Their Current Approach to Treating MF
FEATURING
Ravi Vij,
Abdulraheem Yacoub
- 135 views
- August 30, 2024
MyCancerHaven
Experts Discuss How They Choose 2L Therapy in MF
FEATURING
Ravi Vij,
Prithviraj Bose
- 167 views
- August 30, 2024
Insights from 2024 EHA Annual Meeting
Top 5 Impactful MPN Abstracts From Summer Conferences
FEATURING
Prithviraj Bose
- 159 views
- July 31, 2024
Vanderbilt University Medical Center (VUMC)
Management of MF After Ruxolitinib Failure
FEATURING
Ashwin Kishtagari
- 227 views
- July 18, 2024
- 2
Icahn School of Medicine at Mount Sinai
Strategies to Overcome Immune Dysregulation in MPNs
FEATURING
Cansu Cimen Bozkus
- 36 views
- July 2, 2024
Icahn School of Medicine at Mount Sinai
Stem Cell Pathways, Aging, and Cancer Evolution in MPN
FEATURING
Catriona Jamieson
- 26 views
- July 2, 2024
Icahn School of Medicine at Mount Sinai
Targeting Mutant Calreticulin in MPN
FEATURING
Ann Mullally
- 53 views
- July 2, 2024
- 1
Yale Cancer Center
Emerging Therapies in MF & PV: Insights From Recent Clinical Trials
FEATURING
Jan Bewersdorf
- 176 views
- May 14, 2024
- 1
Moffitt Cancer Center
Current Treatment Landscape of JAK Inhibitors in MF
FEATURING
Andrew Kuykendall
- 243 views
- May 13, 2024
Winship Cancer Institute - Emory University
Updates on Myeloproliferative Neoplasms Including CML
FEATURING
Anthony Hunter
- 153 views
- May 7, 2024
Indy Hematology Review
Current Approaches in the Treatment of Myeloproliferative Neoplasms
FEATURING
Ayalew Tefferi
- 1,419 views
- May 3, 2024
- 13
Memorial Sloan Kettering Cancer Center
Key Updates in AML, MDS, & MF From ASH
FEATURING
Aaron Goldberg
- 319 views
- May 2, 2024
- 4
Mary Frances McMullin
Quality of Life in Myelofibrosis Patients Treated With Momelotinib
- 222 views
- April 26, 2024
Indy Hematology Review
Evaluation, Diagnosis, Prognostication, and Emerging Therapies for Myeloproliferative Neoplasms
FEATURING
Ayalew Tefferi
- 1,646 views
- April 23, 2024
- 11
Prithviraj Bose
MANIFEST-2 Study: Pelabresib With Ruxolitinib for JAKi-Naïve Patients With Myelofibrosis
- 228 views
- April 22, 2024
- 1
University of Colorado Division of Hematology
2024 Updates in MF
FEATURING
Brandon McMahon
- 79 views
- April 19, 2024
- 1
Indy Hematology Review
2024 Updates on Myelofibrosis and Systemic Mastocytosis
FEATURING
Raajit Rampal
- 375 views
- April 16, 2024
- 1
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: MPN
FEATURING
John Mascarenhas
- 272 views
- March 22, 2024
UChicago Medicine
Overview of Recent Updates in MPNs and MDS
FEATURING
Satyajit Kosuri
- 337 views
- March 20, 2024
- 3
City of Hope
Chronic GVHD: Review Advances in Prevention, Novel Endpoints, and Targeted Strategies
FEATURING
Idoroenyi Amanam
- 221 views
- March 11, 2024
- 1
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
2024 Updates in Myeloproliferative Neoplasms
FEATURING
Elizabeth Hexner
- 319 views
- March 3, 2024
- 1
Louisville Hematology Highlights
Is a Bigger Induction "Hammer" Necessarily Better in Today's Stem Cell Transplantation?
FEATURING
William Tse
- 116 views
- February 27, 2024
- 1
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Advances and Unmet Needs in MPN Treatment
FEATURING
Daniela Cilloni
- 82 views
- February 21, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Updates in the Prognosis and Treatment of Myelofibrosis
FEATURING
Selami Koçak Toprak
- 32 views
- February 21, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Key Biological and Clinical Developments in MPNs
FEATURING
Tariq Mughal
- 113 views
- February 16, 2024
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "MF, ET, and PV - Highlights and Clinical Implications"
FEATURING
Douglas Tremblay
- 412 views
- January 26, 2024
Integrity CE
Collaborative Care in MF - Community and Academic Physicians Discuss Managing a Complicated Case
FEATURING
Luke Fletcher,
Aaron Gerds
- 128 views
- January 24, 2024
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "The Best of MPNs - Highlights & Key Takeaways"
FEATURING
Ruben Mesa
- 368 views
- January 19, 2024
- 3
Total Health
West Oncology Conference: Overview and Updates in MPNs
FEATURING
Jason Chandler
- 114 views
- January 8, 2024
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "PIM1 Kinase Inhibitor TP-3654 for R/R Myelofibrosis"
FEATURING
Lindsay Rein
- 40 views
- December 19, 2023
Insights from 2023 ASH Annual Meeting
Prevalence and Prediction of Ruxolitinib Treatment Emergent Thrombocytopenia in Myelofibrosis
FEATURING
Douglas Tremblay
- 436 views
- December 13, 2023
- 1
5th SOHO Italy Annual Conference
SOHO Italy 2023: Diagnosis and Prognosis of MPNs in the Precision Oncology Era
FEATURING
Tariq Mughal
- 46 views
- November 27, 2023
- 1
5th SOHO Italy Annual Conference
SOHO Italy 2023: WHO 2022 Classification of MPNs - Transitioning From the Optical Into the Molecular Era
FEATURING
Hanan Hamed
- 25 views
- November 27, 2023
5th SOHO Italy Annual Conference
SOHO Italy 2023: Myeloproliferative Neoplasms - A Look Into the Future
FEATURING
Rami Komrokji
- 31 views
- November 27, 2023
5th SOHO Italy Annual Conference
SOHO Italy 2023: A New Pathogenetic Paradigm for Myeloproliferative Neoplasms - The “Circulating Wound”
FEATURING
Alessandro Lucchesi
- 17 views
- November 27, 2023
5th SOHO Italy Annual Conference
SOHO Italy 2023: Pregnancy in MPNs - How to Manage These Patients
FEATURING
Elisabetta Abruzzese
- 36 views
- November 27, 2023
MyCancerHaven
Experts Discuss the Diagnosis & Management of Myelofibrosis
FEATURING
Ravi Vij,
Stephen Oh
- 138 views
- November 16, 2023
- 1
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Next Questions: Myeloproliferative Neoplasms
FEATURING
John Mascarenhas
- 67 views
- October 19, 2023
- 1
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Modern Prognostication in Classic MPNs
FEATURING
Francesco Passamonti
- 50 views
- October 18, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Addressing Anemia in Myelofibrosis
FEATURING
Stephen Oh
- 229 views
- October 18, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Clinical Decision-Making for Patients With Myelofibrosis
FEATURING
Prithviraj Bose
- 77 views
- October 18, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Future Directions in the Management of Myelofibrosis
FEATURING
Andrew Kuykendall
- 93 views
- October 18, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Choosing and Properly Using a JAK Inhibitor in Myelofibrosis
FEATURING
Anthony Hunter
- 96 views
- October 16, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Managing Accelerated and Blast Phase MPN
FEATURING
Olatoyosi Odenike
- 66 views
- October 10, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Novel Non-JAK Inhibitor Therapies for Myelofibrosis
FEATURING
John Mascarenhas
- 233 views
- October 10, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Management of Myelofibrosis in Special Patient Populations
FEATURING
John Mascarenhas
- 152 views
- October 9, 2023